FDA Budget: Compounding Increase Paid With Construction Funding, Efficiencies
This article was originally published in The Tan Sheet
Some planned buildings on the White Oak campus for fiscal 2015 would not be funded and savings from program efficiencies would create the $25 million in new funding for compounding oversight, Hamburg tells House committee.
You may also be interested in...
President Obama’s budget requests less headquarters consolidation funding in fiscal 2015. Outside rent spending in the budget request increased from $116.4 million to $120.9 million due to “escalating costs in commercial rent, security, service contracts and utilities,” according to FDA’s congressional justification.
A 2014 omnibus appropriations bill agreed to by Senate and House appropriators would give FDA $2.55 billion in discretionary funding, a $91 million increase. In news applauded by the device industry, the bill would also make available $85 million in previously sequestered FDA user fees.
The mandates in the FDA Safety and Innovation Act and Drug Quality and Security Act show a lot of congressional confidence in the agency, but FDA commissioner says that members also must provide resources to go with it.